Pharmacological Blockade of Glycoprotein VI Promotes Thrombus Disaggregation in the Absence of Thrombin

Archive ouverte

Ahmed, Muhammad Usman | Kaneva, Valeria | Loyau, Stéphane | Nechipurenko, Dmitry | Receveur, Nicolas | Le Bris, Marion | Janus-Bell, Emily | Didelot, Mélusine | Rauch, Antoine | Susen, Sophie | Chakfé, Nabil | Lanza, François | Gardiner, Elizabeth | Andrews, Robert | Panteleev, Mikhail | Gachet, Christian | Jandrot-Perrus, Martine | Mangin, Pierre

Edité par CCSD ; American Heart Association -

International audience. Objective: Atherothrombosis occurs upon rupture of an atherosclerotic plaque and leads to the formation of a mural thrombus. Computational fluid dynamics and numerical models indicated that the mechanical stress applied to a thrombus increases dramatically as a thrombus grows, and that strong inter-platelet interactions are essential to maintain its stability. We investigated whether GPVI (glycoprotein VI)-mediated platelet activation helps to maintain thrombus stability by using real-time video-microscopy. Approach and Results: We showed that GPVI blockade with 2 distinct Fab fragments promoted efficient disaggregation of human thrombi preformed on collagen or on human atherosclerotic plaque material in the absence of thrombin. ACT017-induced disaggregation was achieved under arterial blood flow conditions, and its effect increased with wall shear rate. GPVI regulated platelet activation within a growing thrombus as evidenced by the loss in thrombus contraction when GPVI was blocked, and the absence of the disaggregating effect of an anti-GPVI agent when the thrombi were fully activated with soluble agonists. The GPVI-dependent thrombus stabilizing effect was further supported by the fact that inhibition of any of the 4 key immunoreceptor tyrosine-based motif signalling molecules, src-kinases, Syk, PI3Kβ, or phospholipase C, resulted in kinetics of thrombus disaggregation similar to ACT017. The absence of ACT017-induced disaggregation of thrombi from 2 afibrinogenemic patients suggests that the role of GPVI requires interaction with fibrinogen. Finally, platelet disaggregation of fibrin-rich thrombi was also promoted by ACT017 in combination with r-tPA (recombinant tissue plasminogen activator). Conclusions: This work identifies an unrecognized role for GPVI in maintaining thrombus stability and suggests that targeting GPVI could dissolve platelet aggregates with a poor fibrin content.

Suggestions

Du même auteur

Role of GPVI/Fibrinogen interplay in platelet activation, thrombus formation and stability. Rôle de l'interaction GPVI/fibrinogène dans l’activation plaquettaire et dans la formation et la stabilisation des thrombi

Archive ouverte | Ahmed, Muhammad Usman | CCSD

GPVI belongs to the immunoglobulin superfamily. It is specifically expressed on platelets and megakaryocytes. Since GPVI-deficient patients suffer from a very mild bleeding diathesis and GPVI-deficient mice do not present a prolon...

Implications of von Willebrand Factor in Inflammatory Bowel Diseases: Beyond Bleeding and Thrombosis

Archive ouverte | Lagrange, Jérémy | CCSD

International audience. Abstract Inflammatory bowel disease (IBD) displays an increased venous and arterial thrombotic risk despite the common occurrence of intestinal bleeding. While some of the mechanisms leading ...

The Role of Platelets and von Willebrand Factor in the Procoagulant Phenotype of Inflammatory Bowel Disease

Archive ouverte | Schellenberg, Célia | CCSD

International audience. Abstract Aims Although the risk of thrombosis is well documented for inflammatory bowel disease [IBD] patients, the underlying pathological mechanism seems to be different from other thrombot...

Chargement des enrichissements...